Shopping Cart
Remove All
Your shopping cart is currently empty
Fusionglycoprotein92-106 is a peptide derived from the respiratory syncytial virus (RSV) fusion protein. It functions as an MHC class I-restricted cytotoxic T lymphocyte (CTL) epitope, with all 15 amino acids effectively recognized by CTLs.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder |
| Description | Fusionglycoprotein92-106 is a peptide derived from the respiratory syncytial virus (RSV) fusion protein. It functions as an MHC class I-restricted cytotoxic T lymphocyte (CTL) epitope, with all 15 amino acids effectively recognized by CTLs. |
| In vitro | Fusion glycoprotein 92-106 forms a complex with Kd heavy chain and β2-microglobulin. |
| In vivo | Administering Fusion glycoprotein 92-106 (100 μg, subcutaneously, twice weekly for 3 weeks) can induce a protective immune response against RSV infection in a BALB/c mouse model. |
| Molecular Weight | 1741.96 |
| Formula | C73H124N22O25S |
| Cas No. | 406477-46-1 |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.